Common misconceptions

Common mistake
Wrong: The loading dose must be reduced in renal failure just like the maintenance dose.
Right: The loading dose is determined by Vd (unchanged in most renal failure cases), so it generally does not need adjustment; only the maintenance dose is reduced.
The loading dose formula is LD = Vd × Css — clearance doesn't appear anywhere in it. Renal failure reduces clearance, not Vd (for most drugs), so the volume you need to fill is the same and the loading dose is unchanged. Only the maintenance dose, which equals CL × Css, gets reduced because you're replacing less drug per unit time. Conflating these two formulas is the single most tested error in this topic.
Common mistake
Wrong: A loading dose is always required when starting a new drug.
Right: A loading dose is indicated only when a rapid therapeutic effect is needed and the drug has a long half-life that would otherwise delay reaching steady state.
A loading dose is a targeted clinical decision, not a default. It's reserved for situations where waiting 4-5 half-lives to reach steady state is dangerous or unacceptable — think status epilepticus, acute arrhythmias, or severe infections. For a drug with a short half-life, steady state is reached quickly anyway, so a loading dose adds complexity without meaningful benefit. Always ask: is the half-life long enough that the delay matters clinically?
Common mistake
Wrong: The maintenance dose is determined by Vd.
Right: Maintenance dose is determined by clearance and target steady-state concentration (Dose rate = CL × Css), not by Vd.
Vd determines where the drug distributes — it tells you the size of the compartment you're filling, which is why it drives the loading dose. But once you're at steady state, the question is purely about replacement: how much drug is being cleared per unit time? That's entirely a clearance question. Maintenance dose rate = CL × Css. Vd plays no role in steady-state maintenance because distribution has already happened.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know both formulas cold: Loading dose = (Vd × target Css) / bioavailability; Maintenance dose rate = (CL × target Css) / bioavailability — and know which physiologic variable drives each.
  2. Recognize when a loading dose is clinically indicated: only when you need a rapid effect AND the drug has a long half-life that would otherwise delay reaching steady state (e.g., amiodarone, digoxin in acute heart failure, phenytoin in status epilepticus).
  3. In a patient with renal failure, correctly identify that clearance is reduced (so maintenance dose decreases) but Vd is usually unchanged (so loading dose stays the same) — and apply this to real drugs like aminoglycosides or digoxin.

Can you avoid these mistakes?

A patient in status epilepticus needs IV phenytoin. His creatinine clearance is 20 mL/min (normal 100 mL/min). Should you reduce the loading dose, the maintenance dose, both, or neither? Justify using the relevant formula for each.
Drug X has a half-life of 36 hours and requires a target plasma concentration of 10 mg/L. Its Vd is 50 L and its clearance is 1 L/hr. A patient needs an immediate therapeutic effect. Calculate the loading dose and the maintenance infusion rate.
You are starting a patient on amiodarone for atrial fibrillation. A colleague says 'just start the maintenance dose — loading doses aren't always necessary.' What's wrong with this reasoning specifically for amiodarone, and what PK property makes a loading dose appropriate here?
A drug's package insert states that no dose adjustment is needed in renal failure for the initial dose, but the maintenance dose should be halved. Which pharmacokinetic parameter is most likely unchanged in renal failure for this drug, and which is reduced?

Related topics

See how your Anki deck covers this topic.

Upload your deck for a free audit →